These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29643667)

  • 1. Role of Preablative Stimulated Thyroglobulin in Prediction of Nodal and Distant Metastasis on Iodine Whole-Body Scan.
    Prabhu M; Samson S; Reddy A; Venkataramanarao SH; Chandrasekhar NH; Pillai V; Shetty V; Koriokose MA; Vaidhya B; Kannan S
    Indian J Nucl Med; 2018; 33(2):93-98. PubMed ID: 29643667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
    J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Value of Stimulated Thyroglobulin Before the First Radioactive Iodine Treatment in Metastasis for Differentiated Thyroid Carcinoma.
    Ren L; Zhang C; Shen Y; Mo A; Hu Y; Sun J; Yuan C; Wen W
    Clin Lab; 2021 Jun; 67(6):. PubMed ID: 34107643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.
    Küçük ON; Gültekin SS; Aras G; Ibiş E
    Nucl Med Commun; 2006 Mar; 27(3):261-6. PubMed ID: 16479246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative stimulated thyroglobulin level and recurrence risk stratification in differentiated thyroid cancer.
    Yang X; Liang J; Li TJ; Yang K; Liang DQ; Yu Z; Lin YS
    Chin Med J (Engl); 2015 Apr; 128(8):1058-64. PubMed ID: 25881600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to (131)I Therapy in Non-metastatic Differentiated Thyroid CancerPatients with Preablative Stimulated Thyroglobulin above 10 ng/ml.
    Hou M; Zhao T; Yang X; Li J; Li H; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Feb; 38(1):83-7. PubMed ID: 26956862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan.
    Trybek T; Kowalska A; Lesiak J; Młynarczyk J
    Nucl Med Rev Cent East Eur; 2014; 17(2):87-93. PubMed ID: 25088108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
    Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial stimulated thyroglobulin measurements are more specific for detecting distant metastatic differentiated thyroid cancer before radioiodine therapy.
    Zhao T; Liang J; Li T; Gao W; Lin Y
    Chin J Cancer Res; 2017 Jun; 29(3):213-222. PubMed ID: 28729772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of serial preablative thyroglobulin measurements: can we address the impact of thyroid remnants?
    Zhao T; Liang J; Li T; Guo Z; Vinjamuri S; Lin Y
    Nucl Med Commun; 2016 Jun; 37(6):632-9. PubMed ID: 26829063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer.
    Torlontano M; Crocetti U; D'Aloiso L; Bonfitto N; Di Giorgio A; Modoni S; Valle G; Frusciante V; Bisceglia M; Filetti S; Schlumberger M; Trischitta V
    Eur J Endocrinol; 2003 Jan; 148(1):19-24. PubMed ID: 12534353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undetectable or low (<1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients.
    Campennì A; Giovanella L; Pignata SA; Vento A; Alibrandi A; Sturiale L; Laudicella R; Comis AD; Filice R; Giuffrida G; Stipo ME; Giovinazzo S; Trimarchi F; Ruggeri RM; Baldari S
    Oncotarget; 2018 Apr; 9(25):17491-17500. PubMed ID: 29707123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular technology and the recombinant TSH have changed diagnostics of thyroid carcinoma with positive I-131 whole body scan but low serum thyroglobulin.
    Montella L; Caraglia M; Abbruzzese A; Soricelli A; Prete SD; Squame G; Salvatore M
    Exp Mol Med; 2004 Jun; 36(3):268-73. PubMed ID: 15272239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual Thyroid Tissue on Postoperative Diagnostic 131 I Radioactive Whole-Body Scan After Surgery in Differentiated Thyroid Cancer: A Tertiary Referral Centre Experience.
    Prasad R; Rao V; Subash A; Majumdar KS; Sinha P; Kallur K; Nayar RC
    Indian J Surg Oncol; 2022 Mar; 13(1):109-114. PubMed ID: 35462656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer.
    Neshandar Asli I; Siahkali AS; Shafie B; Javadi H; Assadi M
    Mol Imaging Radionucl Ther; 2014 Jun; 23(2):54-9. PubMed ID: 24963446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological evaluation of differentiated thyroid cancer in patients with positive serum thyroglobulin and negative iodine scan.
    Ansari M; Babaei AA; Shafiei B; Javadi H; Assadi M; Nabipour I; Asli IN
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1925-9. PubMed ID: 25010624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcome of (131)I Therapy in Differentiated Thyroid Cancer with Preablative Thyroglobulin below 10 ng/ml.
    Liu XF; Li J; Zhao T; Hou M; Li H; Liang J; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Feb; 38(1):88-92. PubMed ID: 26956863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.